SALES FORECAST: The Swiss pharma giant's third-quarter sales are forecast at 14.89 billion Swiss francs ($17.22 billion), according to a consensus of 11 analysts' estimates compiled by Visible Alpha.

Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...

Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer Jazz Pharmaceuticals released Phase 3 trial ...

In a report released today, Peter Welford from Jefferies maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target ...

ROCHE Holding will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

View Roche Holding AG (RHHBY) current and estimated P/E ratio data provided by Seeking Alpha.